At the heart of the Monash Learning Health System Maturity Matrix lies its fundamental intent: to provide a structured framework for healthcare organizations to evaluate their operational maturity within the broader context of a learning health system. As healthcare evolves, so too does the importance of effective evaluation mechanisms. The maturity matrix serves as a benchmark against which institutions can measure their capabilities in integrating data-driven practices into everyday healthcare delivery, thereby fostering an environment conducive to continuous improvement.

The collaborative design process of this matrix was marked by substantial input from a diverse array of stakeholders, including healthcare providers, policymakers, and patients. Engaging these groups in co-design not only ensures that the tool caters to real-world needs but also establishes a greater sense of ownership among users. Their insights draw attention to the multifaceted nature of healthcare systems, where behavior, culture, and policy interplay to influence outcomes.

The design of the Monash maturity matrix is informed by extensive literature on health systems, quality improvement methodologies, and theories of organizational change. By incorporating these diverse perspectives, the matrix encompasses various dimensions necessary for evaluating maturity, including leadership, technology use, data access, and interprofessional education. This holistic approach is critical, as it recognizes that successful transformation in health systems cannot occur in isolation but requires a comprehensive understanding of multiple interdependent factors.

Moreover, the matrix aims to transcend traditional evaluation frameworks by emphasizing the behavioral aspects of health systems. Recognizing that knowledge alone is insufficient for change, the tool encourages institutions to consider how their cultures and behaviors impact practices. This perspective fosters a more nuanced understanding of the challenges health organizations face and allows for tailored interventions that align with specific needs.

A key component in the application of the Monash LHS Maturity Matrix is its iterative nature, designed to evolve along with the health system itself. Users can repeatedly engage with the matrix, reassessing their positions and identifying areas ripe for improvement. This continuous feedback loop fosters a culture of learning, where insights and adjustments inform ongoing practice, enabling organizations to navigate the shifting landscapes of healthcare delivery effectively.

As the framework is put to test in real-world settings, the researchers are keen to gather data and feedback on its effectiveness. Initial pilot studies are anticipated to provide invaluable insights into how the matrix is utilized across various healthcare environments. These findings will not only refine the tool itself but also contribute to the broader discourse on learning health systems, ultimately bolstering evidence-based practices in healthcare.

The promise of the Monash Learning Health System Maturity Matrix extends beyond merely measuring current capabilities. It serves as a strategic guide for organizations aspiring to cultivate environments that support innovation and adaptability. By illuminating pathways for improvement, the tool empowers health systems to transition from reactive to proactive mindsets, whereby organizations continuously learn from their own practices and those of others.

Furthermore, its application could address real-time challenges faced during crises, as demonstrated during the COVID-19 pandemic. As health systems around the world grappled with the unprecedented demands placed upon them, tools like the maturity matrix could have provided frameworks to navigate rapid changes effectively and learn from those experiences to shape future responses and resilience strategies.

The collaborative nature of the research underscores the importance of interdisciplinary partnerships in shaping effective health system evaluation tools. The convergence of public health experts, data scientists, behavioral scientists, and clinicians enriches the matrix’s development and promotes cross-pollination of ideas. Such partnerships are essential for addressing the complexities of health systems, especially as they adapt to evolving societal needs and expectations.

While the matrix is an ambitious undertaking, it is grounded in the recognition that tools alone are not a panacea; they require a supportive ecosystem for implementation. Stakeholders across the healthcare spectrum must see the value in leveraging the insights derived from the tool, necessitating organizational commitment and an openness to change. This cultural shift is critical for fostering environments where learning and improvement are integral to daily operations.

In conclusion, the Monash Learning Health System Maturity Matrix represents a pivotal advancement in the way healthcare systems can understand and improve their operations. It embodies a comprehensive approach to evaluation that integrates behavioral insights and stakeholder engagement, paving the way for a future where health systems are not just high-functioning but also learning entities capable of adapting to ever-changing landscapes. The collective efforts from the research team and those involved in the co-design process lay a strong foundation that could redefine how healthcare organizations strive for excellence in patient care and operational efficiency.

As this matrix begins to make its mark within the healthcare community, it sparks important conversations about the nature of learning health systems and the substantial role they play in effecting meaningful change. The journey towards maturity in these complex systems is ongoing, and the Monash matrix could very well serve as a key navigational tool along the path to sustained improvement.

Subject of Research: The development and co-design of the Monash Learning Health System Maturity Matrix for measuring and guiding improvement in health systems.

Article Title: The Monash learning health system maturity matrix: codesign of a tool to measure and guide improvement in complex health system behaviour.

Article References:

Rajit, D., Johnson, A., Reeder, S. et al. The Monash learning health system maturity matrix: codesign of a tool to measure and guide improvement in complex health system behaviour. BMC Health Serv Res (2026). https://doi.org/10.1186/s12913-025-13923-y

Image Credits: AI Generated

DOI:

Keywords: Learning Health System, Maturity Matrix, Healthcare Improvement, Co-design, Health Systems Evaluation.

The study’s extensive fieldwork encompassed 2,282 private healthcare providers dispersed across 253 towns in India, a dataset notable for its breadth and representativeness. Through a series of meticulously designed standardized patient visits, the researchers documented that an alarming 70 percent of providers administered antibiotics in cases of pediatric diarrhea despite the absence of bacterial infection indicators. More strikingly, among providers fully aware that antibiotics were not clinically indicated, nearly two-thirds still prescribed them, underscoring a profound dissonance between knowledge and practice.

Quantitatively dissecting the issue, the researchers differentiated between the knowledge gap—providers’ ignorance about appropriate treatment—and the know-do gap—providers’ failure to translate knowledge into action. Their analysis illuminated that merely closing the knowledge gap would effectuate a modest 6 percentage point reduction in inappropriate antibiotic prescriptions. However, bridging the know-do gap promised a fivefold greater impact, potentially curbing misuse by approximately 30 percentage points. This delineation fundamentally reframes the discourse on interventions aimed at antibiotic stewardship.

To unravel the behavioral underpinnings steering this disconnect, the team employed randomized controlled experiments probing provider motivations and beliefs. Contrary to entrenched assumptions, neither financial incentives derived from antibiotic sales nor shortages of oral rehydration salts (ORS)—the WHO-recommended frontline treatment for pediatric diarrhea—significantly influenced prescribing patterns. Instead, providers’ perceptions of patient expectations emerged as the pivotal factor. When patients explicitly voiced a preference for ORS, inappropriate antibiotic prescribing dropped by 17 percentage points on average, a trend especially pronounced in pharmacy settings, which often operate at the interface between clinical guidance and accessibility.

Complementing provider-focused experiments, a discrete choice analysis involving 1,189 caregivers revealed a striking misalignment between provider beliefs and actual patient preferences. Contrary to providers’ assumptions, caregivers demonstrated no preference for providers who prescribed antibiotics over those who recommended ORS. This misperception highlights a critical communication failure at the patient-provider interface, where imagined demands inadvertently drive inappropriate clinical practices.

Zachary Wagner, the study’s corresponding author and an economist at USC’s Center for Economic and Social Research, emphasized the transformative potential of these findings. He noted, “Our data reveal a striking disconnect: clinicians know antibiotics are wrong for most diarrhea cases, yet prescribe them anyway because they think parents expect ‘strong’ medicines.” He further articulated that reshaping provider perceptions of patient preferences, rather than inundating clinicians with additional didactic training, represents a strategic leverage point for global antibiotic stewardship efforts.

Echoing this sentiment, coauthor Neeraj Sood of USC’s Schaeffer Center and Price School underscored the broader ramifications of unnecessary antibiotic use in children, particularly in fostering antimicrobial resistance—a global public health threat transcending national boundaries. “By showing that patient–provider communication trumps financial motives,” Sood stated, “we give policymakers a laser-focused lever: help doctors understand real patient preferences.” His insights call for a paradigm shift from financial or supply-side interventions toward nuanced social and behavioral strategies.

The study’s granular data further reveal that less formally trained providers and pharmacies—notably the health system’s frontline access points—exhibited the largest know-do gaps. These settings, often characterized by informal or semi-formal service delivery, are uniquely sensitive to caregiver preference signaling. Interventions empowering caregivers to articulate their treatment expectations, alongside public awareness campaigns dispelling myths of antibiotic demand, could thus unlock outsized reductions in misuse. Manoj Mohanan of Duke University highlighted this potential, stating, “Interventions that empower caregivers to voice a preference for ORS, or public campaigns signaling that parents don’t demand antibiotics, could slash misuse at scale.”

Importantly, the research suggests that conventional methods focusing on provider knowledge dissemination or financial incentives are unlikely to succeed in isolation. Providing ORS stock or altering point-of-sale profit structures did not meaningfully change prescribing behavior, revealing the imperative to engage more deeply with psychosocial and communication dimensions of healthcare delivery.

By conducting randomized experiments in real-world clinical settings, the study reinforces the utility of experimental economics methodologies in health systems research. This approach elucidates causal mechanisms driving behavior, offering a replicable model for tackling complex challenges in global health.

As antimicrobial resistance continues to mount as a global crisis, representing a looming threat to modern medicine and public health, these findings offer a compelling blueprint for intervention. They advocate for targeted, contextually sensitive strategies that recognize the intricacies of patient-provider dynamics and cultural norms within India’s healthcare ecosystem.

In sum, the research unveils a powerful truth: tackling antibiotic overuse necessitates more than merely imparting knowledge or adjusting financial incentives. It demands reimagining the relational fabric of clinical decision-making, placing caregiver preferences and communication at the forefront of stewardship initiatives. This revelation not only augurs well for India—one of the largest antibiotic consumers worldwide—but also offers transferable lessons for healthcare systems globally wrestling with similar challenges.

The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under grant number 5R01DK126049, exemplifying the crucial role of sustained investment in interdisciplinary research bridging economics, medicine, and behavioral science.

Subject of Research: Antibiotic overprescribing and behavioral drivers in pediatric diarrhea treatment

Article Title: Investigating the know-do gap in antibiotics prescribing: Experimental evidence from India

News Publication Date: 23 September 2025

Web References:

• https://doi.org/10.1126/sciadv.ady9868
• http://dx.doi.org/10.1126/sciadv.ady9868

References:
Zachary Wagner, Manoj Mohanan, Arnab Mukherji, Rushil Zutshi, Sumeet Patil, Jagadish Krishnappa, Somalee Banerjee, Neeraj Sood. Investigating the know-do gap in antibiotics prescribing: Experimental evidence from India. Science Advances, 10 September 2025.

Keywords: Public health, Antibiotics, Know-do gap, Pediatric diarrhea, India, Antibiotic stewardship, Patient-provider communication, Behavioral economics